This company listing is no longer active
MTCR Stock Overview
Metacrine, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing therapies for patients with gastrointestinal diseases. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Community vs My Fair Value
Create NarrativeSelect a narrative for quick price alerts from the community, or create your own.
Metacrine, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.58 |
| 52 Week High | US$0.59 |
| 52 Week Low | US$0.30 |
| Beta | -0.74 |
| 1 Month Change | 3.82% |
| 3 Month Change | 1.60% |
| 1 Year Change | 23.70% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -95.06% |
Recent News & Updates
Shareholder Returns
| MTCR | US Biotechs | US Market | |
|---|---|---|---|
| 7D | 1.1% | 0.09% | 5.3% |
| 1Y | 23.7% | -14.9% | 11.5% |
Return vs Industry: MTCR exceeded the US Biotechs industry which returned 13.8% over the past year.
Return vs Market: MTCR exceeded the US Market which returned 13.8% over the past year.
Price Volatility
| MTCR volatility | |
|---|---|
| MTCR Average Weekly Movement | 3.7% |
| Biotechs Industry Average Movement | 11.8% |
| Market Average Movement | 8.1% |
| 10% most volatile stocks in US Market | 16.7% |
| 10% least volatile stocks in US Market | 4.2% |
Stable Share Price: MTCR has not had significant price volatility in the past 3 months.
Volatility Over Time: MTCR's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2014 | 10 | Dave Maggio | www.metacrine.com |
Metacrine, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing therapies for patients with gastrointestinal diseases. It is developing MET642, which has completed Phase I clinical trial for the treatment of ulcerative colitis. Metacrine, Inc. was incorporated in 2014 and is headquartered in San Diego, California.
Metacrine, Inc. Fundamentals Summary
| MTCR fundamental statistics | |
|---|---|
| Market cap | US$25.48m |
| Earnings (TTM) | -US$38.19m |
| Revenue (TTM) | n/a |
0.0x
P/S Ratio-0.7x
P/E RatioIs MTCR overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MTCR income statement (TTM) | |
|---|---|
| Revenue | US$0 |
| Cost of Revenue | US$19.49m |
| Gross Profit | -US$19.49m |
| Other Expenses | US$18.70m |
| Earnings | -US$38.19m |
Last Reported Earnings
Sep 30, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.87 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 37.2% |
How did MTCR perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2023/06/22 16:57 |
| End of Day Share Price | 2023/06/20 00:00 |
| Earnings | 2022/09/30 |
| Annual Earnings | 2021/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Metacrine, Inc. is covered by 6 analysts. of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Edward Nash | Canaccord Genuity |
| Joshua Schimmer | Evercore ISI |
| Antonio Arce | H.C. Wainwright & Co. |